Literature DB >> 21438723

Enhanced killing of human epidermoid carcinoma (KB) cells by treatment with ricin encapsulated into sterically stabilized liposomes in combination with monensin.

Nikhil Tyagi1, Shailendra Singh Rathore, Prahlad C Ghosh.   

Abstract

Ricin was encapsulated in various charged liposomes having 5 mol% PEG of different chain length on the surface. The cytotoxicity of ricin entrapped in these liposomal formulations was examined in human epidermoid carcinoma (KB) cells with a view to develop an optimum delivery system for ricin in vivo. It was observed that the cytotoxicity of ricin entrapped in various charged liposomes was significantly dependent on the surface charge as well as chain length of PEG. The maximum cytotoxicity of ricin was observed when it was delivered through negatively charged liposomes having 5 mol% PEG-2000 on the surface. Monensin enhances the cytotoxicity of ricin entrapped in various charged liposomes depending on the surface charge. Maximum potentiation of cytotoxicity of ricin was observed when it was delivered through negatively charged liposomes having 5 mol% PEG-2000 on the surface. Studies on the kinetics of inhibition of protein synthesis by ricin revealed that the lag period of inhibition of protein synthesis is significantly lengthened following its delivery through various charged liposomes. Monensin significantly reduced the lag period of action of ricin. It was also observed that the efficacies of monensin on the enhancement of cytotoxicity of ricin entrapped in various charged PEG-liposomes were highly related to their amount of cell association. The current study has demonstrated that by suitable adjustment of charge, density, and chain length of PEG on the surface of liposomes it would be possible to direct liposomal ricin to human tumor cells for their selective elimination in combination with monensin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21438723     DOI: 10.3109/10717544.2011.567309

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  6 in total

Review 1.  Potential therapeutic applications of plant toxin-ricin in cancer: challenges and advances.

Authors:  Nikhil Tyagi; Monika Tyagi; Manendra Pachauri; Prahlad C Ghosh
Journal:  Tumour Biol       Date:  2015-09-09

2.  Efficacy of Liposomal Monensin on the Enhancement of the Antitumour Activity of Liposomal Ricin in Human Epidermoid Carcinoma (KB) Cells.

Authors:  N Tyagi; S S Rathore; P C Ghosh
Journal:  Indian J Pharm Sci       Date:  2013-01       Impact factor: 0.975

Review 3.  Modulation of microRNAs by phytochemicals in cancer: underlying mechanisms and translational significance.

Authors:  Sanjeev K Srivastava; Sumit Arora; Courey Averett; Seema Singh; Ajay P Singh
Journal:  Biomed Res Int       Date:  2015-03-17       Impact factor: 3.411

4.  Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapy.

Authors:  Sumit Arora; Suresh K Swaminathan; Ameya Kirtane; Sanjeev K Srivastava; Arun Bhardwaj; Seema Singh; Jayanth Panyam; Ajay P Singh
Journal:  Int J Nanomedicine       Date:  2014-06-18

5.  Antibiotic monensin synergizes with EGFR inhibitors and oxaliplatin to suppress the proliferation of human ovarian cancer cells.

Authors:  Youlin Deng; Junhui Zhang; Zhongliang Wang; Zhengjian Yan; Min Qiao; Jixing Ye; Qiang Wei; Jing Wang; Xin Wang; Lianggong Zhao; Shun Lu; Shengli Tang; Maryam K Mohammed; Hao Liu; Jiaming Fan; Fugui Zhang; Yulong Zou; Junyi Liao; Hongbo Qi; Rex C Haydon; Hue H Luu; Tong-Chuan He; Liangdan Tang
Journal:  Sci Rep       Date:  2015-12-07       Impact factor: 4.379

Review 6.  Deubiquitinases and cancer: A snapshot.

Authors:  Nishant Singh; Anuradha Bharara Singh
Journal:  Crit Rev Oncol Hematol       Date:  2016-05-06       Impact factor: 6.312

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.